These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16764663)

  • 1. Acute retinal necrosis post intravitreal injection of triamcinolone acetonide.
    Toh T; Borthwick JH
    Clin Exp Ophthalmol; 2006; 34(4):380-2. PubMed ID: 16764663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.
    Gillies MC; Simpson JM; Billson FA; Luo W; Penfold P; Chua W; Mitchell P; Zhu M; Hunyor AB
    Arch Ophthalmol; 2004 Mar; 122(3):336-40. PubMed ID: 15006845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
    Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
    Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
    Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
    Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.
    Challa JK; Gillies MC; Penfold PL; Gyory JF; Hunyor AB; Billson FA
    Aust N Z J Ophthalmol; 1998 Nov; 26(4):277-81. PubMed ID: 9843254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
    Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
    Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ptosis following an intravitreal injection of triamcinolone acetonide.
    Viola F; Morescalchi F; Ratiglia R; Staurenghi G
    Eye (Lond); 2007 Mar; 21(3):421-3. PubMed ID: 16498434
    [No Abstract]   [Full Text] [Related]  

  • 10. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
    Ho TC
    Ophthalmologica; 2006; 220(6):409; author reply 410. PubMed ID: 17095890
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
    Jonas JB; Akkoyun I; Budde WM; Kreissig I; Degenring RF
    Arch Ophthalmol; 2004 Feb; 122(2):218-22. PubMed ID: 14769599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Amat P; Lugo FL
    J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
    Aggermann T; Stolba U; Brunner S; Binder S
    Ophthalmologica; 2006; 220(2):131-3. PubMed ID: 16491037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute visual loss and chorioretinal infarction after photodynamic therapy combined with intravitreal triamcinolone.
    Lo Giudice G; De Belvis V; Piermarocchi S; Galan A; Prosdocimo G
    Eur J Ophthalmol; 2008; 18(4):652-5. PubMed ID: 18609494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide: a change in a paradigm.
    Jonas JB
    Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
    Jonas JB; Spandau UH; Kamppeter BA; Harder B
    Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.